-- MediSwitch Drug Interactions Import (Part 87/112)
INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(12628, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(12628, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(23748, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(23748, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(23748, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(23748, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(23748, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(23748, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(23748, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(23748, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(23748, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(23748, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(23748, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(23748, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(23748, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(23748, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(23748, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(23748, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(23748, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(23748, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(23748, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(23748, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(23748, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(23748, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(23748, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(23748, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(23748, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(23748, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(23748, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(23748, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(23748, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(23748, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(23748, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(23748, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(23748, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(23748, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(23748, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(23748, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(23748, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(23748, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(23748, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(23748, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(23748, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(23748, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(23748, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(23748, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(23748, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(23748, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(23748, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(23748, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(23748, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(23748, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(23748, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(23748, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(23748, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(23748, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(23748, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(23748, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(23748, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(23748, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(23748, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(23748, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(23748, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(23748, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(23748, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(23748, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(23748, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(23748, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(23748, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(23748, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(23748, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(23748, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(23748, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(23748, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(23748, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(23748, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(23748, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(23748, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(23748, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13965, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(13965, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(13965, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(13965, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(13965, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(13965, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(13965, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(13965, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(13965, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(13965, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(13965, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(13965, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(13965, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(13965, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(13965, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(13965, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(13965, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(13965, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(13965, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(13965, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(13965, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(13965, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(13965, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(13965, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(13965, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(13965, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(13965, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(13965, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(13965, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(13965, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(13965, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13965, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(13965, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(13965, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13965, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(13965, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(13965, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(13965, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(13965, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(13965, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(13965, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(13965, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(13965, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(13965, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(13965, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(13965, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(13965, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(13965, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(13965, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(13965, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13965, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13965, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(13965, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(13965, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(13965, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13965, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(13965, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(13965, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(13965, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(13965, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(13965, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13965, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(13965, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(13965, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(13965, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13965, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(13965, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13965, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13965, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(13965, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(13965, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(13965, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(13965, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13965, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13965, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13965, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(13965, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29903, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(29903, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(29903, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(29903, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(29903, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(29903, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(29903, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(29903, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(29903, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(29903, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(29903, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(29903, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(29903, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(29903, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(29903, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(29903, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(29903, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(29903, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(29903, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(29903, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(29903, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(29903, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(29903, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(29903, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(29903, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(29903, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(29903, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(29903, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(29903, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(29903, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(29903, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(29903, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(29903, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(29903, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29903, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(29903, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(29903, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(29903, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(29903, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(29903, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(29903, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(29903, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(29903, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(29903, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(29903, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(29903, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(29903, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(29903, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(29903, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(29903, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(29903, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(29903, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(29903, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(29903, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(29903, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(29903, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(29903, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(29903, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(29903, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(29903, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(29903, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(29903, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(29903, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(29903, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(29903, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(29903, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(29903, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(29903, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29903, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(29903, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(29903, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(29903, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(29903, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(29903, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29903, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29903, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(29903, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13749, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(13749, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(13749, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(13749, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(13749, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(13749, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(13749, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(13749, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(13749, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(13749, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(13749, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(13749, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(13749, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(13749, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(13749, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(13749, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(13749, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(13749, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(13749, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(13749, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(13749, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(13749, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(13749, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(13749, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(13749, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(13749, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(13749, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(13749, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(13749, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(13749, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(13749, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13749, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(13749, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(13749, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13749, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(13749, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(13749, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(13749, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(13749, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(13749, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(13749, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(13749, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(13749, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(13749, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(13749, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(13749, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(13749, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(13749, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(13749, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(13749, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13749, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13749, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(13749, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(13749, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(13749, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13749, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(13749, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(13749, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(13749, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(13749, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(13749, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13749, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(13749, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(13749, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(13749, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13749, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(13749, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(13749, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13749, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(13749, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(13749, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(13749, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(13749, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13749, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13749, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13749, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(13749, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29041, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(29041, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(29041, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(29041, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(29041, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(29041, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(29041, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(29041, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(29041, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(29041, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(29041, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(29041, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(29041, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(29041, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(29041, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(29041, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(29041, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(29041, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(29041, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(29041, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(29041, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(29041, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(29041, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(29041, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(29041, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(29041, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(29041, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(29041, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(29041, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(29041, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(29041, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(29041, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(29041, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(29041, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29041, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(29041, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(29041, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(29041, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(29041, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(29041, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(29041, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(29041, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(29041, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(29041, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(29041, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(29041, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(29041, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(29041, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(29041, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(29041, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(29041, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(29041, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(29041, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(29041, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(29041, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(29041, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(29041, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(29041, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(29041, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(29041, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(29041, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(29041, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(29041, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(29041, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(29041, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(29041, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(29041, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(29041, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29041, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(29041, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(29041, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(29041, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(29041, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(29041, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29041, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29041, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(29041, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(21295, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(21295, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(21295, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(21295, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(21295, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(21295, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(21295, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(21295, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(21295, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(21295, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(21295, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(21295, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(21295, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(21295, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(21295, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(21295, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(21295, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(21295, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(21295, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(21295, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(21295, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(21295, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(21295, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(21295, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(21295, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(21295, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(21295, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(21295, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(21295, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(21295, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(21295, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(21295, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(21295, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(21295, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(21295, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(21295, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(21295, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(21295, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(21295, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(21295, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(21295, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(21295, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(21295, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(21295, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(21295, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(21295, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(21295, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(21295, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(21295, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(21295, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(21295, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(21295, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(21295, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(21295, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(21295, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(21295, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(21295, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(21295, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(21295, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(21295, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(21295, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(21295, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(21295, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(21295, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(21295, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(21295, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(21295, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(21295, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(21295, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(21295, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(21295, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(21295, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(21295, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(21295, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(21295, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(21295, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(21295, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(22069, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(22069, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(22069, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(22069, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(22069, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(22069, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(22069, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(22069, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(22069, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(22069, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(22069, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(22069, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(22069, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(22069, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(22069, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(22069, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(22069, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(22069, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(22069, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(22069, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(22069, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(22069, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(22069, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(22069, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(22069, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(22069, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(22069, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(22069, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(22069, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(22069, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(22069, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(22069, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(22069, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(22069, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(22069, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(22069, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(22069, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(22069, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(22069, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(22069, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(22069, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(22069, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(22069, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(22069, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(22069, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(22069, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(22069, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(22069, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(22069, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(22069, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(22069, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(22069, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(22069, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(22069, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(22069, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(22069, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(22069, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(22069, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(22069, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(22069, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(22069, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(22069, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(22069, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(22069, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(22069, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(22069, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(22069, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(22069, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(22069, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(22069, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(22069, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(22069, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(22069, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(22069, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(22069, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(22069, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(22069, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29026, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(29026, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(29026, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(29026, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(29026, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(29026, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(29026, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(29026, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(29026, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(29026, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(29026, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(29026, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(29026, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(29026, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(29026, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(29026, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(29026, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(29026, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(29026, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(29026, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(29026, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(29026, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(29026, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(29026, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(29026, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(29026, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(29026, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(29026, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(29026, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(29026, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(29026, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(29026, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(29026, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(29026, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29026, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(29026, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(29026, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(29026, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(29026, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(29026, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(29026, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(29026, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(29026, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(29026, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(29026, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(29026, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(29026, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(29026, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(29026, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(29026, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(29026, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(29026, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(29026, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(29026, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(29026, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(29026, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(29026, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(29026, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(29026, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(29026, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(29026, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(29026, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(29026, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(29026, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(29026, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(29026, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(29026, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(29026, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29026, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(29026, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(29026, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(29026, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(29026, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(29026, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29026, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29026, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(29026, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(8507, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(8507, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(8507, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(8507, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(8507, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(8507, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(8507, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(8507, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(8507, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(8507, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(8507, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(8507, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(8507, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(8507, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(8507, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(8507, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(8507, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(8507, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(8507, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(8507, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(8507, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(8507, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(8507, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(8507, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(8507, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(8507, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(8507, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(8507, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(8507, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(8507, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(8507, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(8507, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(8507, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(8507, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(8507, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(8507, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(8507, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(8507, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(8507, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(8507, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(8507, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(8507, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(8507, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(8507, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(8507, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(8507, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(8507, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(8507, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(8507, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(8507, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(8507, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(8507, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(8507, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(8507, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(8507, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(8507, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(8507, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(8507, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(8507, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(8507, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(8507, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(8507, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(8507, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(8507, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(8507, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(8507, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(8507, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(8507, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(8507, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(8507, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(8507, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(8507, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(8507, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(8507, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(8507, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(8507, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(8507, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(21863, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(21863, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(21863, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(21863, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(21863, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(21863, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(21863, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(21863, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(21863, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(21863, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(21863, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(21863, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(21863, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(21863, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(21863, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(21863, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(21863, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(21863, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(21863, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(21863, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(21863, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(21863, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(21863, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(21863, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(21863, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(21863, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(21863, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(21863, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(21863, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(21863, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(21863, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(21863, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(21863, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(21863, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(21863, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(21863, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(21863, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(21863, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(21863, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(21863, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(21863, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(21863, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(21863, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(21863, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(21863, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(21863, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(21863, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(21863, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(21863, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(21863, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(21863, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(21863, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(21863, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(21863, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(21863, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(21863, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(21863, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(21863, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(21863, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(21863, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(21863, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(21863, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(21863, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(21863, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(21863, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(21863, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(21863, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(21863, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(21863, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(21863, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(21863, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(21863, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(21863, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(21863, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(21863, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(21863, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(21863, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(696, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(696, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(696, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(696, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(696, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(696, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(696, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(696, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(696, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(696, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(696, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(696, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(696, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(696, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(696, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(696, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(696, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(696, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(696, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(696, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(696, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(696, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(696, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(696, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(696, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(696, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(696, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(696, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(696, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(696, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(696, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(696, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(696, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(696, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(696, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(696, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(696, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(696, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(696, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(696, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(696, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(696, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(696, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(696, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(696, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(696, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(696, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(696, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(696, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(696, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(696, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(696, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(696, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(696, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(696, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(696, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(696, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(696, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(696, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(696, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(696, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(696, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(696, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(696, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(696, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(696, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(696, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(696, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(696, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(696, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(696, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(696, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(696, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(696, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(696, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(696, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(696, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(14771, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(14771, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(14771, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(14771, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(14771, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(14771, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(14771, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(14771, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(14771, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(14771, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(14771, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(14771, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(14771, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(14771, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(14771, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(14771, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(14771, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(14771, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(14771, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(14771, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(14771, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(14771, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(14771, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(14771, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(14771, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(14771, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(14771, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(14771, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(14771, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(14771, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(14771, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(14771, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(14771, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(14771, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(14771, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(14771, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(14771, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(14771, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(14771, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(14771, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(14771, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(14771, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(14771, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(14771, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(14771, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(14771, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(14771, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(14771, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(14771, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(14771, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(14771, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(14771, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(14771, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(14771, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(14771, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(14771, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(14771, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(14771, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(14771, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(14771, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(14771, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(14771, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(14771, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(14771, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(14771, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(14771, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(14771, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(14771, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(14771, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(14771, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(14771, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(14771, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(14771, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(14771, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(14771, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(14771, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(14771, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(15854, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(15854, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(15854, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(15854, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(15854, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(15854, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(15854, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(15854, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(15854, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(15854, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(15854, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(15854, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(15854, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(15854, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(15854, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(15854, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(15854, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(15854, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(15854, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(15854, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(15854, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(15854, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(15854, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(15854, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(15854, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(15854, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(15854, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(15854, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(15854, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(15854, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(15854, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(15854, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(15854, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(15854, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(15854, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(15854, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(15854, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(15854, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(15854, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(15854, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(15854, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(15854, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(15854, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(15854, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(15854, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(15854, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(15854, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(15854, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(15854, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(15854, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(15854, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(15854, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(15854, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(15854, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(15854, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(15854, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(15854, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(15854, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(15854, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(15854, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(15854, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(15854, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(15854, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(15854, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(15854, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(15854, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(15854, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(15854, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(15854, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(15854, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(15854, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(15854, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(15854, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(15854, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(15854, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(15854, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(15854, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(4332, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(4332, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(4332, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(4332, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(4332, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(4332, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(4332, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(4332, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(4332, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(4332, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(4332, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(4332, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(4332, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(4332, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(4332, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(4332, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(4332, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(4332, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(4332, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(4332, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(4332, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(4332, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(4332, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(4332, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(4332, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(4332, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(4332, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(4332, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(4332, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(4332, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(4332, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(4332, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(4332, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(4332, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(4332, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(4332, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(4332, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(4332, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(4332, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(4332, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(4332, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(4332, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(4332, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(4332, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(4332, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(4332, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(4332, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(4332, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(4332, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(4332, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(4332, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(4332, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(4332, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(4332, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(4332, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(4332, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(4332, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(4332, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(4332, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(4332, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(4332, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(4332, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(4332, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(4332, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(4332, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(4332, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(4332, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(4332, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(4332, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(4332, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(4332, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(4332, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(4332, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(4332, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(4332, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(4332, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(4332, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(28921, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(28921, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(28921, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(28921, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(28921, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(28921, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(28921, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(28921, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(28921, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(28921, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(28921, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(28921, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(28921, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(28921, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(28921, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(28921, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(28921, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(28921, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(28921, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(28921, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(28921, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(28921, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(28921, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(28921, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(28921, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(28921, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(28921, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(28921, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(28921, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(28921, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(28921, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(28921, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(28921, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(28921, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(28921, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(28921, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(28921, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(28921, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(28921, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(28921, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(28921, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(28921, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(28921, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(28921, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(28921, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(28921, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(28921, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(28921, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(28921, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(28921, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(28921, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(28921, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(28921, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(28921, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(28921, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(28921, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(28921, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(28921, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(28921, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(28921, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(28921, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(28921, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(28921, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(28921, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(28921, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(28921, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(28921, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(28921, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(28921, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(28921, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(28921, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(28921, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(28921, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(28921, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(28921, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(28921, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(28921, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(12626, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(12626, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(12626, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(12626, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(12626, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(12626, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(12626, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(12626, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(12626, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(12626, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(12626, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(12626, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(12626, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(12626, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(12626, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(12626, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(12626, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(12626, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(12626, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(12626, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(12626, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(12626, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(12626, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(12626, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(12626, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(12626, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(12626, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(12626, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(12626, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(12626, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(12626, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(12626, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(12626, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(12626, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(12626, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(12626, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(12626, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(12626, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(12626, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(12626, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(12626, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(12626, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(12626, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(12626, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(12626, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(12626, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(12626, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(12626, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(12626, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(12626, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(12626, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(12626, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(12626, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(12626, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(12626, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(12626, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(12626, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(12626, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(12626, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(12626, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(12626, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(12626, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(12626, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(12626, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(12626, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(12626, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(12626, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(12626, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(12626, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(12626, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(12626, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(12626, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(12626, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(12626, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(12626, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(12626, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(12626, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29042, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(29042, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(29042, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(29042, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(29042, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(29042, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(29042, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(29042, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(29042, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(29042, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(29042, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(29042, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(29042, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(29042, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(29042, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(29042, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(29042, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(29042, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(29042, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(29042, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(29042, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(29042, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(29042, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(29042, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(29042, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(29042, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(29042, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(29042, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(29042, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(29042, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(29042, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(29042, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(29042, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(29042, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29042, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(29042, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(29042, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(29042, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(29042, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(29042, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(29042, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(29042, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(29042, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(29042, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(29042, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(29042, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(29042, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(29042, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(29042, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(29042, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(29042, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(29042, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(29042, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(29042, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(29042, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(29042, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(29042, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(29042, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(29042, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(29042, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(29042, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(29042, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(29042, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(29042, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(29042, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(29042, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(29042, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(29042, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29042, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(29042, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(29042, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(29042, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(29042, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(29042, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29042, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29042, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(29042, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(18177, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(18177, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(18177, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(18177, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(18177, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(18177, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(18177, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(18177, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(18177, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(18177, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(18177, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(18177, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(18177, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(18177, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(18177, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(18177, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(18177, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(18177, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(18177, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(18177, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(18177, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(18177, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(18177, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(18177, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(18177, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(18177, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(18177, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(18177, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(18177, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(18177, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(18177, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(18177, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(18177, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(18177, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(18177, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(18177, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(18177, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(18177, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(18177, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(18177, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(18177, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(18177, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(18177, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(18177, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(18177, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(18177, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(18177, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(18177, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(18177, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(18177, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(18177, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(18177, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(18177, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(18177, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(18177, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(18177, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(18177, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(18177, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(18177, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(18177, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(18177, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(18177, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(18177, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(18177, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(18177, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(18177, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(18177, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(18177, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(18177, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(18177, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(18177, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(18177, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(18177, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(18177, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(18177, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(18177, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(18177, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(14744, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(14744, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(14744, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(14744, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(14744, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(14744, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(14744, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(14744, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(14744, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(14744, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(14744, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(14744, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(14744, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(14744, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(14744, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(14744, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(14744, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(14744, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(14744, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(14744, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(14744, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(14744, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(14744, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(14744, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(14744, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(14744, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(14744, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(14744, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(14744, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(14744, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(14744, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(14744, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(14744, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(14744, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(14744, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(14744, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(14744, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(14744, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(14744, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(14744, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(14744, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(14744, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(14744, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(14744, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(14744, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(14744, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(14744, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(14744, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(14744, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(14744, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(14744, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(14744, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(14744, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(14744, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(14744, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(14744, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(14744, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(14744, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(14744, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(14744, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(14744, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(14744, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(14744, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(14744, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(14744, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(14744, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(14744, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(14744, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(14744, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(14744, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(14744, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(14744, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(14744, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(14744, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(14744, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(14744, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(14744, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(20528, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(20528, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(20528, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(20528, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(20528, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(20528, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(20528, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(20528, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(20528, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(20528, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(20528, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(20528, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(20528, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(20528, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(20528, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(20528, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(20528, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(20528, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(20528, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(20528, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(20528, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(20528, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(20528, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(20528, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(20528, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(20528, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(20528, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(20528, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(20528, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(20528, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(20528, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(20528, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(20528, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(20528, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(20528, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(20528, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(20528, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(20528, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(20528, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(20528, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(20528, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(20528, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(20528, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(20528, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(20528, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(20528, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(20528, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(20528, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(20528, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(20528, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(20528, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(20528, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(20528, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(20528, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(20528, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(20528, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(20528, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(20528, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(20528, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(20528, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(20528, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(20528, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(20528, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(20528, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(20528, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(20528, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(20528, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(20528, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(20528, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(20528, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(20528, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(20528, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(20528, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(20528, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(20528, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(20528, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(20528, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(10540, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(10540, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(10540, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(10540, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(10540, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(10540, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(10540, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(10540, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(10540, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(10540, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(10540, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(10540, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(10540, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(10540, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(10540, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(10540, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(10540, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(10540, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(10540, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(10540, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(10540, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(10540, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(10540, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(10540, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(10540, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(10540, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(10540, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(10540, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(10540, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(10540, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(10540, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(10540, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(10540, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(10540, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(10540, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(10540, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(10540, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(10540, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(10540, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(10540, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(10540, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(10540, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(10540, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(10540, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(10540, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(10540, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(10540, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(10540, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(10540, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(10540, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(10540, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(10540, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(10540, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(10540, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(10540, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(10540, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(10540, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(10540, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(10540, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(10540, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(10540, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(10540, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(10540, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(10540, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(10540, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(10540, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(10540, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(10540, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(10540, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(10540, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(10540, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(10540, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(10540, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(10540, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(10540, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(10540, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(10540, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(22224, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(22224, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(22224, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(22224, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(22224, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(22224, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(22224, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(22224, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(22224, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(22224, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(22224, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(22224, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(22224, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(22224, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(22224, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(22224, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(22224, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(22224, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(22224, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(22224, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(22224, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(22224, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(22224, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(22224, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(22224, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(22224, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(22224, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(22224, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(22224, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(22224, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(22224, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(22224, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(22224, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(22224, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(22224, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(22224, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(22224, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(22224, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(22224, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(22224, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(22224, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(22224, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(22224, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(22224, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(22224, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(22224, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(22224, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(22224, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(22224, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(22224, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(22224, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(22224, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(22224, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(22224, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(22224, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(22224, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(22224, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(22224, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(22224, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(22224, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(22224, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(22224, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(22224, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(22224, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(22224, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(22224, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(22224, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(22224, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(22224, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(22224, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(22224, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(22224, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(22224, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(22224, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(22224, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(22224, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(22224, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(32142, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(32142, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(32142, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(32142, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(32142, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(32142, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(32142, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(32142, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(32142, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(32142, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(32142, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(32142, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(32142, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(32142, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(32142, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(32142, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(32142, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(32142, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(32142, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(32142, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(32142, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(32142, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(32142, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(32142, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(32142, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(32142, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(32142, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(32142, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(32142, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(32142, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(32142, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(32142, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(32142, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(32142, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(32142, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(32142, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(32142, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(32142, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(32142, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(32142, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(32142, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(32142, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(32142, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(32142, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(32142, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(32142, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(32142, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(32142, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(32142, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(32142, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(32142, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(32142, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(32142, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(32142, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(32142, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(32142, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(32142, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(32142, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(32142, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(32142, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(32142, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(32142, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(32142, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(32142, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(32142, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(32142, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(32142, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(32142, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(32142, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(32142, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(32142, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(32142, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(32142, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(32142, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(32142, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(32142, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(32142, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13959, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(13959, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(13959, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(13959, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(13959, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(13959, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(13959, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(13959, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(13959, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(13959, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(13959, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(13959, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(13959, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(13959, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(13959, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(13959, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(13959, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(13959, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(13959, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(13959, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(13959, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(13959, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(13959, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(13959, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(13959, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(13959, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(13959, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(13959, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(13959, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(13959, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(13959, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13959, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(13959, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(13959, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13959, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(13959, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(13959, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(13959, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(13959, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(13959, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(13959, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(13959, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(13959, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(13959, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(13959, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(13959, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(13959, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(13959, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(13959, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(13959, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13959, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13959, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(13959, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(13959, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(13959, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13959, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(13959, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(13959, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(13959, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(13959, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(13959, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13959, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(13959, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(13959, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(13959, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13959, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(13959, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13959, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13959, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(13959, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(13959, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(13959, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(13959, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13959, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13959, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13959, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(13959, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13963, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(13963, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(13963, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(13963, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(13963, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(13963, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(13963, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(13963, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(13963, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(13963, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(13963, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(13963, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(13963, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(13963, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(13963, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(13963, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(13963, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(13963, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(13963, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(13963, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(13963, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(13963, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(13963, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(13963, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(13963, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(13963, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(13963, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(13963, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(13963, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(13963, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(13963, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13963, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(13963, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(13963, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13963, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(13963, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(13963, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(13963, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(13963, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(13963, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(13963, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(13963, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(13963, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(13963, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(13963, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(13963, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(13963, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(13963, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(13963, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(13963, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(13963, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13963, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(13963, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(13963, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(13963, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13963, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(13963, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(13963, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(13963, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(13963, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(13963, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13963, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(13963, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(13963, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(13963, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13963, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(13963, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13963, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13963, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(13963, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(13963, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(13963, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(13963, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13963, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13963, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13963, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(13963, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(355, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(355, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(355, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(355, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(355, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(355, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(355, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(355, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(355, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(355, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(355, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(355, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(355, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(355, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(355, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(355, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(355, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(355, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(355, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(355, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(355, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(355, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(355, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(355, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(355, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(355, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(355, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(355, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(355, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(355, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(355, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(355, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(355, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(355, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(355, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(355, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(355, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(355, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(355, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(355, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(355, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(355, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(355, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(355, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(355, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(355, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(355, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(355, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(355, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(355, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(355, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(355, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(355, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(355, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(355, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(355, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(355, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(355, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(355, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(355, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(355, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(355, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(355, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(355, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(355, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(355, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(355, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(355, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(355, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(355, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(355, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(355, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(355, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(355, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(355, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(355, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(355, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(15383, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(15383, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(15383, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(15383, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(15383, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(15383, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(15383, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(15383, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(15383, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(15383, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(15383, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(15383, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(15383, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(15383, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(15383, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(15383, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(15383, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(15383, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(15383, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(15383, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(15383, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(15383, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(15383, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(15383, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(15383, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(15383, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(15383, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(15383, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(15383, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(15383, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(15383, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(15383, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(15383, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(15383, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(15383, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(15383, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(15383, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(15383, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(15383, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(15383, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(15383, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(15383, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(15383, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(15383, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(15383, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(15383, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(15383, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(15383, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(15383, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(15383, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(15383, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(15383, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(15383, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(15383, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(15383, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(15383, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(15383, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(15383, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(15383, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(15383, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(15383, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(15383, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(15383, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(15383, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(15383, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(15383, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(15383, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(15383, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(15383, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(15383, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(15383, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(15383, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(15383, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(15383, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(15383, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(15383, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(15383, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13928, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(13928, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(13928, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(13928, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(13928, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(13928, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(13928, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(13928, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(13928, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(13928, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(13928, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(13928, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(13928, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(13928, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(13928, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(13928, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(13928, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(13928, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(13928, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(13928, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(13928, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(13928, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(13928, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(13928, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(13928, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(13928, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(13928, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(13928, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(13928, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(13928, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(13928, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13928, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(13928, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(13928, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13928, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(13928, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(13928, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(13928, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(13928, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(13928, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(13928, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(13928, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(13928, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(13928, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(13928, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(13928, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(13928, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(13928, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(13928, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(13928, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13928, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13928, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(13928, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(13928, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(13928, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13928, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(13928, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(13928, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(13928, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(13928, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(13928, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13928, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(13928, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(13928, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(13928, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13928, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(13928, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13928, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13928, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(13928, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(13928, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(13928, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(13928, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13928, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13928, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13928, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(13928, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(11821, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(11821, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(11821, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(11821, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(11821, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(11821, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(11821, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(11821, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(11821, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(11821, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(11821, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(11821, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(11821, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(11821, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(11821, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(11821, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(11821, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(11821, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(11821, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(11821, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(11821, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(11821, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(11821, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(11821, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(11821, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(11821, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(11821, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(11821, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(11821, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(11821, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(11821, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(11821, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(11821, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(11821, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(11821, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(11821, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(11821, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(11821, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(11821, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(11821, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(11821, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(11821, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(11821, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(11821, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(11821, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(11821, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(11821, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(11821, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(11821, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(11821, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(11821, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(11821, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(11821, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(11821, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(11821, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(11821, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(11821, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(11821, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(11821, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(11821, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(11821, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(11821, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(11821, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(11821, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(11821, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(11821, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(11821, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(11821, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(11821, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(11821, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(11821, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(11821, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(11821, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(11821, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(11821, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(11821, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(11821, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(32031, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(32031, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(32031, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(32031, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(32031, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(32031, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(32031, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(32031, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(32031, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(32031, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(32031, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(32031, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(32031, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(32031, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(32031, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(32031, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(32031, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(32031, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(32031, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(32031, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(32031, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(32031, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(32031, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(32031, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(32031, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(32031, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(32031, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(32031, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(32031, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(32031, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(32031, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(32031, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(32031, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(32031, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(32031, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(32031, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(32031, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(32031, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(32031, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(32031, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(32031, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(32031, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(32031, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(32031, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(32031, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(32031, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(32031, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(32031, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(32031, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(32031, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(32031, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(32031, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(32031, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(32031, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(32031, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(32031, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(32031, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(32031, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(32031, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(32031, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(32031, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(32031, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(32031, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(32031, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(32031, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(32031, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(32031, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(32031, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(32031, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(32031, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(32031, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(32031, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(32031, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(32031, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(32031, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(32031, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(32031, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(10875, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(10875, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(10875, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(10875, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(10875, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(10875, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(10875, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(10875, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(10875, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(10875, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(10875, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(10875, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(10875, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(10875, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(10875, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(10875, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(10875, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(10875, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(10875, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(10875, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(10875, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(10875, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(10875, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(10875, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(10875, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(10875, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(10875, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(10875, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(10875, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(10875, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(10875, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(10875, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(10875, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(10875, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(10875, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(10875, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(10875, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(10875, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(10875, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(10875, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(10875, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(10875, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(10875, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(10875, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(10875, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(10875, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(10875, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(10875, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(10875, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(10875, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(10875, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(10875, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(10875, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(10875, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(10875, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(10875, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(10875, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(10875, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(10875, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(10875, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(10875, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(10875, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(10875, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(10875, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(10875, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(10875, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(10875, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(10875, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(10875, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(10875, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(10875, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(10875, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(10875, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(10875, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(10875, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(10875, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(10875, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(22226, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(22226, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(22226, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(22226, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(22226, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(22226, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(22226, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(22226, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(22226, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(22226, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(22226, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(22226, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(22226, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(22226, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(22226, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(22226, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(22226, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(22226, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(22226, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(22226, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(22226, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(22226, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(22226, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(22226, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(22226, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(22226, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(22226, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(22226, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(22226, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(22226, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(22226, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(22226, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(22226, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(22226, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(22226, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(22226, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(22226, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(22226, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(22226, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(22226, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(22226, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(22226, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(22226, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(22226, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(22226, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(22226, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(22226, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(22226, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(22226, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(22226, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(22226, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(22226, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(22226, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(22226, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(22226, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(22226, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(22226, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(22226, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(22226, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(22226, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(22226, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(22226, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(22226, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(22226, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(22226, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(22226, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(22226, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(22226, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(22226, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(22226, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(22226, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(22226, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(22226, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(22226, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(22226, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(22226, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(22226, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(14772, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(14772, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(14772, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(14772, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(14772, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(14772, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(14772, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(14772, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(14772, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(14772, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(14772, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(14772, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(14772, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(14772, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(14772, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(14772, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(14772, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(14772, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(14772, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(14772, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(14772, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(14772, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(14772, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(14772, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(14772, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(14772, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(14772, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(14772, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(14772, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(14772, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(14772, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(14772, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(14772, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(14772, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(14772, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(14772, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(14772, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(14772, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(14772, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(14772, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(14772, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(14772, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(14772, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(14772, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(14772, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(14772, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(14772, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(14772, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(14772, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(14772, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(14772, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(14772, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(14772, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(14772, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(14772, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(14772, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(14772, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(14772, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(14772, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(14772, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(14772, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(14772, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(14772, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(14772, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(14772, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(14772, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(14772, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(14772, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(14772, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(14772, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(14772, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(14772, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(14772, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(14772, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(14772, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(14772, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(14772, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(17152, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(17152, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(17152, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(17152, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(17152, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(17152, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(17152, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(17152, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(17152, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(17152, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(17152, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(17152, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(17152, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(17152, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(17152, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(17152, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(17152, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(17152, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(17152, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(17152, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(17152, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(17152, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(17152, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(17152, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(17152, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(17152, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(17152, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(17152, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(17152, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(17152, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(17152, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(17152, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(17152, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(17152, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(17152, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(17152, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(17152, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(17152, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(17152, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(17152, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(17152, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(17152, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(17152, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(17152, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(17152, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(17152, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(17152, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(17152, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(17152, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(17152, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(17152, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(17152, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(17152, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(17152, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(17152, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(17152, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(17152, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(17152, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(17152, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(17152, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(17152, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(17152, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(17152, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(17152, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(17152, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(17152, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(17152, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(17152, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(17152, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(17152, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(17152, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(17152, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(23553, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(23553, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(23553, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(23553, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(23553, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(23553, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(23553, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(23553, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(23553, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(23553, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(23553, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(23553, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(23553, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(23553, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(23553, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(23553, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(23553, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(23553, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(23553, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(23553, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(23553, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(23553, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(23553, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(23553, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(23553, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(23553, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(23553, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(23553, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(23553, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(23553, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(23553, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(23553, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(23553, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(23553, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(23553, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(23553, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(23553, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(23553, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(23553, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(23553, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(23553, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(23553, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(23553, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(23553, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(23553, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(23553, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(23553, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(23553, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(23553, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(23553, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(23553, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(23553, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(23553, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(23553, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(23553, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(23553, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(23553, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(23553, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(23553, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(23553, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(23553, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(23553, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(23553, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(23553, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(23553, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(23553, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(23553, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(23553, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(23553, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(23553, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(23553, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(23553, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(23553, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(23553, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(23553, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(23553, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(23553, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13962, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(13962, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(13962, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(13962, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(13962, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(13962, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(13962, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(13962, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(13962, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(13962, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(13962, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(13962, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(13962, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(13962, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(13962, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(13962, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(13962, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(13962, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(13962, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(13962, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(13962, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(13962, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(13962, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(13962, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(13962, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(13962, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(13962, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(13962, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(13962, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(13962, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(13962, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13962, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(13962, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(13962, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13962, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(13962, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(13962, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(13962, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(13962, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(13962, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(13962, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(13962, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(13962, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(13962, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(13962, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(13962, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(13962, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(13962, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(13962, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(13962, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13962, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13962, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(13962, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(13962, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(13962, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13962, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(13962, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(13962, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(13962, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(13962, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(13962, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13962, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(13962, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(13962, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(13962, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(13962, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(13962, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13962, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13962, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(13962, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(13962, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(13962, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(13962, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(13962, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13962, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(13962, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(13962, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(28527, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(28527, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(28527, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(28527, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(28527, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(28527, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(28527, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(28527, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(28527, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(28527, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(28527, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(28527, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(28527, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(28527, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(28527, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(28527, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(28527, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(28527, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(28527, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(28527, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(28527, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(28527, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(28527, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(28527, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(28527, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(28527, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(28527, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(28527, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(28527, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(28527, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(28527, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(28527, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(28527, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(28527, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(28527, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(28527, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(28527, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(28527, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(28527, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(28527, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(28527, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(28527, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(28527, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(28527, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(28527, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(28527, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(28527, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(28527, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(28527, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(28527, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(28527, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(28527, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(28527, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(28527, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(28527, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(28527, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(28527, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(28527, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(28527, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(28527, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(28527, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(28527, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(28527, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(28527, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(28527, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(28527, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(28527, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(28527, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(28527, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(28527, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(28527, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(28527, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(28527, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(28527, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(28527, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(28527, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(28527, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29901, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(29901, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(29901, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(29901, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(29901, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(29901, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(29901, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(29901, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(29901, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(29901, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(29901, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(29901, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(29901, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(29901, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(29901, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(29901, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(29901, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(29901, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(29901, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(29901, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(29901, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(29901, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(29901, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(29901, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(29901, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(29901, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(29901, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(29901, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(29901, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(29901, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(29901, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(29901, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(29901, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(29901, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29901, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(29901, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(29901, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(29901, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(29901, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(29901, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(29901, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(29901, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(29901, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(29901, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(29901, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(29901, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(29901, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(29901, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(29901, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(29901, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(29901, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(29901, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(29901, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(29901, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed');

INSERT INTO drug_interactions (med_id, interaction_drug_name, interaction_dailymed_id, severity, description, source) VALUES
(29901, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(29901, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(29901, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(29901, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(29901, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(29901, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(29901, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(29901, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(29901, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(29901, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(29901, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(29901, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(29901, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(29901, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29901, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(29901, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(29901, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(29901, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(29901, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(29901, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29901, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(29901, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(29901, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(8508, 'amlodipine besylate', 'N/A', 'major', 'Drug Interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on amlodipine CIMETIDINE: Coadministration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine.GRAPEFRUIT JUICE: Coadministration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.MAALOX (antacid): Coadministration of the antacid Maalox with a single dose of amlodipine had no significant effect on the pharmacokinetics of amlodipine.SILDENAFIL: A single 100 mg dose of sildenafil (Viagra®) in subjects with essential hypertension had no effect on the pharmacokinetic parameters ', 'DailyMed'),
(8508, 'tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(8508, 'fosamprenavir calcium', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑Calcium channel blockers Use with caution.', 'DailyMed'),
(8508, 'saquinavir mesylate', 'N/A', 'moderate', 'Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine ↑ Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(8508, 'aliskiren hemifumarate and hydrochlorothiazide', 'N/A', 'major', 'Coadministration of aliskiren with Pgp substrates or weak to moderate inhibitors such as atenolol, digoxin, and amlodipine did not result in clinically relevant interactions. Drugs with no clinically significant effects: Coadministration of lovastatin, atenolol, warfarin, furosemide, digoxin, celecoxib, hydrochlorothiazide, ramipril, valsartan, metformin and amlodipine did not result in clinically significant increases in aliskiren exposure. Drugs with no clinically significant effects: Coadministration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.', 'DailyMed'),
(8508, 'amlobenz', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(8508, 'valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS No clinically significant pharmacokinetic interactions were observed when Diovan (valsartan) was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(8508, 'amlodipine besylate, arginine', 'N/A', 'major', 'Drug Interactions: In vitro data indicate that amlodipine besylate has no effect on the humanplasma protein binding of digoxin, phenytoin, warfarin, and indomethacin. Effect of other agents on Amlodipine besylate.CIMETIDINE: Co-administration of amlodipine besylate with cimetidine did not alter thepharmacokinetics of amlodipine besylate. GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose ofamlodipine 10 mg in 20 healthy volunteers had no significant effect on the C6H6O3Spharmacokinetics of amlodipine.', 'DailyMed'),
(8508, 'amlodipine besylate and benazepril hydrochloride', 'N/A', 'moderate', '7 DRUG INTERACTIONS {template} Potassium supplements / Potassium-sparing diuretics: risk of hyperkalemia Lithium: Increased serum lithium levels; toxicity symptoms Injectable gold: facial flushing, nausea, vomiting, or hypotension may occur 7.1 Drug/Drug interactions Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with amlodipine besylate and benazepril hydrochloride. The possibility of hypotensive effects with amlodipine besylate and benazepril hydrochloride can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with amlodipine besylate and benazepril hydrochloride. When coadminis', 'DailyMed'),
(8508, 'amlodipine valsartan and hydrochlorothiazide', 'N/A', 'major', 'Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of amlodipine with cimetidine did not alter the pharmacokinetics of amlodipine. Grapefruit juice: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.', 'DailyMed'),
(8508, 'valsartan and hydrochlorothiazide', 'N/A', 'major', '7 DRUG INTERACTIONS Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(8508, 'amlodipine besylate and olmesartan medoxomil', 'N/A', 'major', '7 DRUG INTERACTIONS Enter section text here 7.1 Drug Interactions with Azor The pharmacokinetics of amlodipine and olmesartan medoxomil are not altered when the drugs are co-administered. No drug interaction studies have been conducted with Azor and other drugs, although studies have been conducted with the individual amlodipine and olmesartan medoxomil components of Azor, as described below, and no significant drug interactions have been observed. 7.2 Drug Interactions with Amlodipine In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.', 'DailyMed'),
(8508, 'amlodipine besylate and valsartan', 'N/A', 'major', '7 DRUG INTERACTIONS If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) NSAIDS use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7) 7.1 Drug/Drug Interactions No drug interaction studies have been conducted with Exforge and other drugs, although studies have been conducted with the individual amlodipine and valsartan components, as described below: Studies with Amlodipine In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs. Cimetidine: Co-administration of ', 'DailyMed'),
(8508, 'warfarin sodium', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalut', 'DailyMed'),
(8508, 'telmisartan', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen.', 'DailyMed'),
(8508, 'telmisartan and hydrochlorothiazide', 'N/A', 'major', 'Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glibenclamide, simvastatin, hydrochlorothiazide or ibuprofen.', 'DailyMed'),
(8508, 'simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.4) Interacting Agents Prescribing Recommendations Itraconazole, ketoconazole, Posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, nefazodone, gemfibrozil, cyclosporine,danazol Contraindicated with simvastatin Verapamil, diltiazem Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers ', 'DailyMed'),
(8508, 'clarithromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS – Drug Interactions).', 'DailyMed'),
(8508, 'telithromycin', 'N/A', 'minor', '(See CLINICAL PHARMACOLOGY, Drug-drug interactions.) Hypotension, bradyarrhythmia and loss of consciousness have been observed in patients receiving concomitant treatment with calcium channel blockers that are substrates of CYP 3A4 (e.g., verapamil, amlodipine, diltiazem).', 'DailyMed'),
(8508, 'amlodipine besylate and atorvastatin calcium', 'N/A', 'minor', 'Drug Interactions Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which was not clinically meaningful. No drug interaction studies have been conducted with amlodipine besylate/atorvastatin calcium tablets and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Studies with Amlodipine In vitro data in ', 'DailyMed'),
(8508, 'ezetimibe and simvastatin', 'N/A', 'contraindicated', '7 DRUG INTERACTIONS [See Clinical Pharmacology (12.3).] VYTORIN Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 4, 5.1, 7.1, 7.2, 7.3, 7.6, 7.8, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 Inhibitors, (e.g., itraconazole, ketoconazole, posaconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with VYTORIN Verapamil, diltiazem Do not exceed 10/10 mg VYTORIN daily Amiodarone, amlodipine, ranolazine Do not exceed 10/20 mg VYTORIN daily Grapefruit juice Avoid large quantities of grapefruit juice (>1 quart daily) Coumarin anticoagulants: simvastatin prolongs INR. 7.3 Amiodarone, Ranolazine, or Calcium Channel Blockers The risk', 'DailyMed'),
(8508, 'fluconazole', 'N/A', 'minor', 'Calcium Channel Blockers: Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(8508, 'ketoconazole', 'N/A', 'minor', 'Alfentanil, fentanyl, sulfentanil Indinavir, saquinavir Amlodipine, felodipine, nicardipine, nifedipine Methylprednisolone Bosentan Rifabutin Buspirone Sildenafil Busulfan Sirolimus (co-administration not recommended) Carbamazepine Tacrolimus Cilostazol Telithromycin Cyclosporine Tolterodine Digoxin Trimetrexate Docetaxel, paclitaxel Verapamil Oral anti-coagulants Vinca alkaloids (vincristine, - vinblastine, vinorelbine) Table 2. Amlodipine, felodipine, nicardipine, nifedipine CYP3A4 metabolized calcium channel blockers such as amlodipine, felodipine, nicardipine, and nifedipine should be used cautiously with ketoconazole tablets as ketoconazole may cause several-fold increases in plasma concentrations of these calcium channel blockers.', 'DailyMed'),
(8508, 'warfarin', 'N/A', 'minor', 'Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicaluta', 'DailyMed'),
(8508, 'elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate', 'N/A', 'minor', 'Amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Concentrations of calcium channel blockers may be increased when coadministered with STRIBILD.', 'DailyMed'),
(8508, 'sildenafil', 'N/A', 'minor', 'Amlodipine. When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic.', 'DailyMed'),
(8508, 'amlodipine and valsartan', 'N/A', 'minor', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with Amlodipine and Valsartan Tablets and other drugs, although studies have been conducted with the individual amlodipine and valsartan components. Studies with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.', 'DailyMed'),
(8508, 'benazepril hydrochloride', 'N/A', 'minor', 'The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine.', 'DailyMed'),
(8508, 'sildenafil citrate', 'N/A', 'moderate', '7.3 Amlodipine When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see Warnings and Precautions (5.5), Clinical Pharmacology (12.2) ].', 'DailyMed'),
(8508, 'erythromycin', 'N/A', 'moderate', 'These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem) (see PRECAUTIONS - Drug Interactions ).', 'DailyMed'),
(8508, 'amlodipine and benazepril hydrochloride', 'N/A', 'moderate', '(7.1) 7.1 Drug/Drug I nteractions Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. Limit the dose of simvastatin in patients on amlodipine to 20 mg daily. CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(8508, 'fluconazole, sodium chloride', 'N/A', 'minor', 'Calcium Channel Blockers Certain dihydropyridine calcium channel antagonists (nifedipine, isradipine, amlodipine, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(8508, 'amlodipine and olmesartan medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine ( 7.1): If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin. Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(8508, 'olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(8508, 'colchicine', 'N/A', 'minor', '7.4 Drug Interaction Studies Two pharmacokinetic studies evaluated the effects of co-administration of posaconazole (300 mg QD), ciprofloxacin (500 mg BID), amlodipine (5 to 10 mg QD), and carvedilol (20 to 40 mg QD) on the systemic levels of colchicine. GLOPERBA can be administered with amlodipine, carvedilol, and ciprofloxacin at the tested doses without a need for dose adjustment.', 'DailyMed'),
(8508, 'perindopril arginine and amlodipine besylate', 'N/A', 'minor', 'Prestalia The pharmacokinetics of perindopril and amlodipine are not altered when the drugs are co-administered. No drug interaction studies have been conducted with PRESTALIA, although studies have been conducted with perindopril and amlodipine. Amlodipine Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin administered alone.', 'DailyMed'),
(8508, 'temsirolimus', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blockers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(8508, 'magnesium sulfate heptahydrate', 'N/A', 'moderate', 'Examples: Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: Reduced magnesium concentrations may impact efficacy Intervention: Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(8508, 'amlodipine besylate  and olmesartran medoxomil', 'N/A', 'minor', '7 DRUG INTERACTIONS Amlodipine (7.1): • If simvastatin is co-administered with amlodipine, do not exceed 20 mg daily of simvastatin. • Increased exposure of amlodipine when coadministered with CYP3A inhibitors. 7.1 Drug Interactions with Amlodipine Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(8508, 'levamlodipine', 'N/A', 'moderate', '( 7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)] CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine. Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.', 'DailyMed'),
(8508, 'amlodipine', 'N/A', 'moderate', '(7.2) 7.1 Impact of Other Drugs on Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction. Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment [see Clinical Pharmacology (12.3)]. CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.', 'DailyMed'),
(8508, 'lomitapide mesylate', 'N/A', 'minor', '7.2 Weak CYP3A4 Inhibitors Weak CYP3A4 inhibitors (such as alprazolam, amiodarone, amlodipine, atorvastatin, bicalutamide, cilostazol, cimetidine, cyclosporine, fluoxetine, fluvoxamine, ginkgo, goldenseal, isoniazid, lapatinib, nilotinib, pazopanib, ranitidine, ranolazine, ticagrelor, zileuton) can increase lomitapide exposure approximately 2-fold [see Clinical Pharmacology (12.3)].', 'DailyMed'),
(8508, 'dofetilide', 'N/A', 'minor', 'Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of dofetilide.', 'DailyMed'),
(8508, 'temsirolimus injection', 'N/A', 'moderate', '7.3 Angioedema with ACE inhibitors and Calcium Channel Blokers Angioedema has been reported in patients taking mammalian target of rapamycin (mTOR) inhibitors in combination with ramipril and/or amlodipine. Monitor patients for signs and symptoms of angioedema when temsirolimus is given concomitantly with an angiotensin converting enzyme (ACE) inhibitors (e.g., ramipril) or calcium channel blockers (CCB) (e.g., amlodipine).', 'DailyMed'),
(8508, 'finasteride and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood-pressure-lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendrofluazide, enalapril, and metoprolol).', 'DailyMed'),
(8508, 'telmisartan and amlodipine', 'N/A', 'minor', '7 DRUG INTERACTIONS NSAIDS: Increased risk of renal impairment and loss of antihypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with telmisartan and amlodipine tablets in patients with diabetes (7.2) 7.1 Drug Interactions with Telmisartan and Amlodipine Tablets The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered. No drug interaction studies have been conducted with telmisartan and amlodipine tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of telmisartan and amlodipine tablets, as described below: 7.2 Drug Interactions with Telmisartan Aliskiren: Do no', 'DailyMed'),
(8508, 'olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide', 'N/A', 'minor', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. 2 Drug Interactions with Amlodipine Simvastatin:Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.', 'DailyMed'),
(8508, 'valsartan/htcz', 'N/A', 'major', 'Valsartan: No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin.', 'DailyMed'),
(8508, 'darunavir', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(8508, 'amlodipine, valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of other Drugs on Amlodipine CYP3A Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(8508, 'darunavir ethanolate and cobicistat', 'N/A', 'moderate', 'Amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(8508, 'darunavir 600 mg', 'N/A', 'moderate', 'Calcium Channel Blockers: amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring of patients is recommended.', 'DailyMed'),
(8508, 'magnesium sulfate', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(8508, 'atorvastatin calcium', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(8508, 'darunavir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium channel blockers: e.g., amlodipine, diltiazem, felodipine, nifedipine, verapamil ↑ calcium channel blockers Clinical monitoring is recommended for co-administration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(8508, 'avanafil', 'N/A', 'minor', 'A clinical pharmacology trial was conducted to assess the effect of STENDRA on the potentiation of the blood pressure-lowering effects of selected antihypertensive medications (amlodipine and enalapril). CYP3A4 Substrate When administered with STENDRA 200 mg, amlodipine (5 mg daily) increased the Cmax and AUC of avanafil by approximately 22% and 70%, respectively. The Cmax and AUC of amlodipine decreased by approximately 9% and 4%, respectively [see Dosage and Administration (2.3) ].', 'DailyMed'),
(8508, 'atorvaliq', 'N/A', 'minor', '40 mg SD 1.37 1.16 Diltiazem 240 mg QD, 28 days 40 mg SD 1.51 1.00 Erythromycin 500 mg QIDFour times daily, 7 days 10 mg SD 1.33 1.38 Amlodipine 10 mg, single dose 80 mg SD 1.18 0.91 Cimetidine 300 mg QID, 2 weeks 10 mg QDfor 2 weeks 1.00 0.89 Colestipol 10 g BID, 24 weeks 40 mg QD for 8 weeks NA 0.74Ratio based on a single sample taken 8-16 h post dose.', 'DailyMed'),
(8508, 'amlodipine and atorvastatin', 'N/A', 'minor', '7 DRUG INTERACTIONS Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered. The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful. No drug interaction studies have been conducted with amlodipine and atorvastatin and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Amlodipine See full prescribing information for details regar', 'DailyMed'),
(8508, 'erythromycin lactobionate', 'N/A', 'moderate', 'Verapamil, amlodipine, diltiazem, vasospasm and ischemia with ergotamine/dihydroergotamine) (See PRECAUTIONS – Drug Interactions ).', 'DailyMed'),
(8508, 'ferric citrate', 'N/A', 'minor', '7 DRUG INTERACTIONS Table 2: Oral drugs that can be administered concomitantly with Auryxia Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Auryxia and meals Dosing Recommendations Doxycycline Take at least 1 hour before Auryxia Ciprofloxacin Take at least 2 hours before or after Auryxia Oral medications not listed in Table 2 There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs.', 'DailyMed'),
(8508, 'amlodipine,valsartan and hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine, valsartan and hydrochlorothiazide tablets and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine, valsartan and hydrochlorothiazide tablets, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(8508, 'elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g.,amlodipinediltiazemfelodipinenicardipinenifedipineverapamil ↑ calcium channel blockers Caution is warranted and clinical monitoring is recommended upon coadministration of calcium channel blockers with GENVOYA.', 'DailyMed'),
(8508, 'patiromer', 'N/A', 'major', 'Table 3: No observed clinically important drug interactions of Veltassa Angiotensin-converting enzyme (ACE) inhibitors Benazepril, captopril, enalapril, fosinopril, lisinopril, perindopril, quinapril, ramipril, trandolapril Angiotensin II receptor blockers (ARB) Azilsartan, candesartan, irbesartan, losartan, olmesartan, valsartan β-adrenoceptor blockers (β-blocker) Metoprolol Loop diuretics Furosemide, bumetanide, torasemide Mineralocorticoid receptor antagonists (MRA) Eplerenone, finerenone, spironolactone Neprilysin inhibitors Sacubitril Sodium-glucose cotransporter-2 (SGLT-2) inhibitors Canagliflozin, dapagliflozin, empagliflozin Antibiotics Trimethoprim, amoxicillin, cephalexin Anticoagulants Warfarin, apixaban, rivaroxaban Anti-parathyroid agents and Thyroid preparations Cinacalcet An', 'DailyMed'),
(8508, 'lansoprazole, amoxicillin, clarithromycin', 'N/A', 'minor', 'Amlodipine Diltiazem Amlodipine, Diltiazem: (see WARNINGS ).', 'DailyMed'),
(8508, 'amlodipine besylate valsartan hydrochlorothiazide', 'N/A', 'moderate', '7 DRUG INTERACTIONS No drug interaction studies have been conducted with amlodipine/valsartan/hydrochlorothiazide and other drugs, although studies have been conducted with the individual components. A pharmacokinetic drug-drug interaction study has been conducted to address the potential for pharmacokinetic interaction between the triple combination, amlodipine/valsartan/hydrochlorothiazide, and the corresponding 3 double combinations. Amlodipine Impact of Other Drugs on Amlodipine CYP3A Inhibitors Coadministration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.', 'DailyMed'),
(8508, 'macitentan and tadalafil', 'N/A', 'minor', 'Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood–pressure–lowering effects of selected antihypertensive medications (amlodipine, angiotensin II receptor blockers, bendroflumethiazide, enalapril, and metoprolol).', 'DailyMed'),
(8508, 'atazanavir and cobicistat', 'N/A', 'moderate', 'Calcium channel blockers: (e.g., amlodipine, diltiazem, felodipine, nifedipine, and verapamil) ↑ calcium channel blocker Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(8508, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): Limit simvastatin to 20 mg daily when coadministered. Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(8508, 'glecaprevir and pibrentasvir', 'N/A', 'major', '7.5 Drugs with No Observed Clinically Significant Interactions with MAVYRET No dose adjustment is required when MAVYRET is coadministered with the following medications: abacavir, amlodipine, caffeine, dextromethorphan, dolutegravir, elvitegravir/ cobicistat, emtricitabine, ethinyl estradiol of 20 mcg or less, felodipine, lamivudine, lamotrigine, losartan, midazolam, norethindrone or other progestin-only contraceptives, omeprazole, raltegravir, rilpivirine, sofosbuvir, tacrolimus, tenofovir alafenamide, tenofovir disoproxil fumarate, tolbutamide, and valsartan.', 'DailyMed'),
(8508, 'magnesium sulfate in dextrose', 'N/A', 'moderate', 'Examples: •Amlodipine, clevidipine, felodipine, isradipine, nicardipine, nifedipine, nimodipine, and nisoldipine Drugs that May Induce Magnesium Loss Clinical Impact: •Reduced magnesium concentrations may impact efficacy Intervention: •Monitor magnesium concentrations frequently and adjust the Magnesium Sulfate in 5% Dextrose Injection dosage to maintain concentrations in the target range [see Dosage and Administration (2)].', 'DailyMed'),
(8508, 'fluconazole in sodium chloride', 'N/A', 'minor', 'Calcium channel blockers Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4.', 'DailyMed'),
(8508, 'nirmatrelvir and ritonavir', 'N/A', 'moderate', 'Calcium channel blockers amlodipine, diltiazem,felodipine,nicardipine,nifedipine,verapamil ↑ calcium channel blocker Caution is warranted and clinical monitoring of patients is recommended.', 'DailyMed'),
(8508, 'cobicistat', 'N/A', 'moderate', 'Calcium Channel Blockers: e.g., amlodipinediltiazemfelodipinenifedipineverapamil ↑ calcium channel blockers Clinical monitoring is recommended for coadministration with calcium channel blockers metabolized by CYP3A.', 'DailyMed'),
(8508, 'olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 20/5/12.5 mg', 'N/A', 'moderate', 'Amlodipine ( 7.2): Limit simvastatin to 20 mg daily when coadministered. Increased exposure to cyclosporin and tacrolimus Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide ( 7.3): Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(8508, 'olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): •Limit simvastatin to 20 mg daily when coadministered. •Increased exposure to cyclosporin and tacrolimus •Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): •Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine, and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed'),
(8508, 'vonoprazan fumarate and amoxicillin', 'N/A', 'minor', 'Amlodipine Diltiazem Nifedipine Ergot Alkaloids Clinical Effect Clarithromycin is a strong CYP3A inhibitor.', 'DailyMed'),
(8508, 'olmesartan medoxomil amlodipine and hydrochlorothiazide', 'N/A', 'moderate', 'Amlodipine (7.2): • Limit simvastatin to 20 mg daily when coadministered. • Increased exposure to cyclosporin and tacrolimus • Increased amlodipine exposure when coadministered with CYP3A inhibitors Hydrochlorothiazide (7.3): • Antidiabetic drugs: Dosage adjustment of antidiabetic may be required. Closely monitor blood pressure, renal function and electrolytes in patients on olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets and other agents that affect the RAS.', 'DailyMed');

